Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections.
about
Evidencing the Role of Erythrocytic Apoptosis in Malarial AnemiaExternal quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillanceRNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammationCD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions.Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70.Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum.Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adultsHigh IFN-gamma and TNF production by peripheral NK cells of Colombian patients with different clinical presentation of Plasmodium falciparum.Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients.Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite developmentAnalysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.Expression of multiple granzymes by cytotoxic T lymphocyte implies that they activate diverse apoptotic pathways in target cells.NK Cells: Uncertain Allies against Malaria.The robust and modulated biomarker network elicited by the Plasmodium vivax infection is mainly mediated by the IL-6/IL-10 axis and is associated with the parasite load.Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria.Natural killer cell responses to infections in early life.Effect of malaria components on blood mononuclear cells involved in immune response.Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective?Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum.Cytokines and Chemokines in Cerebral Malaria Pathogenesis.Granzymes A and K differentially potentiate LPS-induced cytokine response.Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin.Antimalarial activity of granzyme B and its targeted delivery by a granzyme B-single-chain Fv fusion protein.Beyond genome-wide scan: Association of a cis-regulatory NCR3 variant with mild malaria in a population living in the Republic of Congo.Controlled Human Malaria Infection: Applications, Advances and Challenges.A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.Natural killer cells and malaria.Dynamics and kinetics of natural killer cell cytotoxicity in human malaria as evaluated by a novel stepwise cytotoxicity assay.Poorly cytotoxic terminally differentiated CD56CD16 NK cells accumulate in Kenyan children with Burkitt lymphomasMicrovesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathwayAntihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand FactorLiver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study
P2860
Q28067004-A63753CF-E702-474A-A2E2-DEEDFC6774BAQ28538917-BF254197-1C5D-438D-9B8F-908D8C84F4B3Q28804081-78AB89FB-EF80-4C09-8224-998E9784F908Q30490447-76D1ACA2-4B2D-4720-918C-239FAFCACC62Q31052590-79E7C310-D0CF-4A00-8634-F06F7E7114BAQ34078591-6AB4570A-22C4-4930-94B1-384745E52F6EQ34673461-6875D60C-6C3C-40D6-B9F6-1FE8ED54DC8CQ35800108-B6FAC556-7F3A-41F9-B715-D5B39D58843FQ36173345-D465483F-F2C3-4BE4-8BF6-57FDF4A93140Q36835495-BBEE2948-013B-4E02-B90B-B989EDF28A90Q37534468-A59D6C64-ED5B-4E3E-B4B7-4621E2D944E6Q37641378-DAEFDF81-A6C5-4262-94FD-1AF5176180C0Q37680983-F97968FC-4C63-4A6A-955E-4D574E2AADC7Q37689434-469AE393-5E0A-40AC-9105-9346197523B9Q37704579-B6B93031-8102-4B36-876E-57963599F6E4Q37770828-1BDA3FA0-D14C-4F11-9F08-B0CCC36A34EEQ37853786-3555E1E2-C72E-4367-BA9B-A174D08F7338Q38133577-A444E28D-530E-4806-9493-6DBED56B2A71Q38516531-B28D3FB3-D80D-45FD-B6E0-A69CFC52FE0BQ38728601-1A51E25D-B6A4-4C1D-83D0-9BDAED48071BQ40107124-DD3409FC-092D-437C-AE80-1E6B11381586Q40393562-B9709F9A-92DE-4C72-9829-1E26E8E49E55Q40473727-5C2D28EA-39E9-4282-820B-C637F920AAC2Q41702248-DB78E0C5-DA0F-40BC-8C86-890F8F54CD97Q43923845-0D691005-C2CF-4EDF-9D0C-467B41425362Q44168331-91ADE3BF-410B-4481-A830-D068E6BA7FD4Q47857250-ED1B0E6C-0B3D-445B-94DE-FF7B510AF1AEQ48036767-0A2D6F1D-B27D-419A-A030-FE85840C702EQ48036832-93AFFCAC-DAB9-4797-80F5-3BCFA4ACF52CQ56380040-F12B922C-C085-4609-8ADD-1A8043CE7D41Q57031388-17B134BC-D415-41F3-85EA-470919B0A12DQ58023226-269014D8-5CEC-43F5-BB1B-6A687333D196Q58714876-4ED4ACAA-59A3-4040-9A12-63BF7F395E83
P2860
Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Circulating concentrations of ...... smodium falciparum infections.
@en
Circulating concentrations of ...... smodium falciparum infections.
@nl
type
label
Circulating concentrations of ...... smodium falciparum infections.
@en
Circulating concentrations of ...... smodium falciparum infections.
@nl
prefLabel
Circulating concentrations of ...... smodium falciparum infections.
@en
Circulating concentrations of ...... smodium falciparum infections.
@nl
P2093
P2860
P1476
Circulating concentrations of ...... smodium falciparum infections.
@en
P2093
C C Hermsen
G J van Mierlo
J W M van der Meer
M van Deuren
R W Sauerwein
W M C Eling
Y Konijnenberg
P2860
P304
P356
10.1046/J.1365-2249.2003.02160.X
P577
2003-06-01T00:00:00Z